Clinical Trial Update: Efficacy and Safety of HRS9531 Injection in Type 2 Diabetes Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial results show efficacy and safety data for HRS9531 injection in adults with type 2 diabetes; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• HRS9531

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED